The consolidated financial results for the quarter ending Dec 31, 2024 (Q3)
The consolidated financial results for the quarter ending Dec 31, 2024 (Q3)
Issuance of bonus shares in a 1:20 ratio and and a preferential allotment of 2,63,71,888 equity shares to raise ₹39.55 crore.
Proposal to raise ₹23.78 crore via private placement and to approve IPO
Private Placement of 135950 Shares @1062
New Fund Raise by Lords Mark
Offering 2,20,22,100 equity shares at ₹92 per share on a 1:1 rights basis
The consolidated financial results for the quarter ending Dec 31, 2024 (Q3)
Veeda Clinical Research Files DRHP For Around 1,000 Cr IPO